Mar 28 – Sharekhan Daily 3R Research Calls – MOIL, Laurus Labs, PNC Infratech Stocks Analysis

Welcome to Sharekhan’s 3R Research Actionable Update series, wherein the Sharekhan Fundamental Research team shares daily opportunities in the capital markets with you to stay on track with your goals!

Discover what full service broking can do for you with share khan’s daily 3r research actionable update hello everyone welcome back to exciting 3r actionable stock updates we 3r basically means right sector right quality and right valuation these are our investment ideas today we have an update on moi limited our analyst maintains y on oil with an unchanged

Price target of rupees 220 as a recent sharp rally of 36 percent in international manganese oil price would drive margin led strong earnings recovery we expect 27 percent paid cagr over fi 21 to 24 earnings mold took a price hike of 10 to 15 percent across various manganese oil grades in march 2020. while india’s aim of 300 million tons of steel production by

Calendar year 30 bodes well for sustained volume growth for moist attractive valuation of 2.3 times f by 23 estimated eb by ebitda healthy dividend of 4 to 5 percent and high cash on the books which is 47 of current market capitalization provides comfort to the investors next update is on laura’s labs the analyst has reiterated by recommendation on loras labs with

An unchanged price target of rupees 735 the analyst recent interaction with management points to an encouraging commentary and strong levers that could drive the growth ahead the finished dosages and synthesis segments have a healthy growth outlook backed by the expected improvement in the demand environment and expanding capacities doubling of tablet capacity to

10 billion tablets would drive finished dosage segment sales while traction in existing contracts and likely new customer addition would aid synthesis segment growth laura’s bios performance is also expected to materially improve backed by the commissioning of new capacities the anti-retroviral api business is on its part to recovery with a material improvement

Likely in quarter one of fy23 and also points at likely sequential improvement higher raw material prices especially solvent prices elevated fret cost could exert margin pressure but levers to offset the same is expected to play out in the near term backed by an expected sequential improvement in the arv apis the quarter 4 of fy22 performance is expected to be

Better than quarter 3. last we have an update on pnc infratech our analyst maintains a buy on pnc infratec with an unchanged price target of rupees 380 considering its healthy growth outlook led by a strong order book and recent order wins pnc’s l1 position in six hybrid annuity model projects with an aggregate bid project cost rupees 6871 crore would help the

Company achieve its 8 000 crore order target for fi 22. the receipt of an early completion bonus for purunjal expressway highlights its strong execution capabilities additionally the fructification of asset divestment would further aid in strengthening its healthy balance sheet we expect rendering activities to pick up post fy 2022 with kovite 19 extended monsoon

And flood-like situation in the southern states affecting business till february 2022. for more detailed disclosures and disclaimers please refer to our research report or contact our nearest branch please read the risk disclosure document issued by sebi and relevant exchanges and terms and condition on before investing tune in again tomorrow for a

New podcast on share khan’s 3r research actionable update click on the subscribe button and never miss another update from share khan investment in securities market are subject to market twists read all the related documents carefully before investing

Transcribed from video
Mar 28 – Sharekhan Daily 3R Research Calls – MOIL, Laurus Labs, PNC Infratech Stocks Analysis By Sharekhan